Cargando…

Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention: A case report

RATIONALE: Primary percutaneous coronary intervention (PPCI) is the most effective therapy for patients with an acute ST-segment elevation myocardial infarction (STEMI). However, up to half of STEMI patients suffer from coronary microvascular dysfunction, presenting as the slow flow or no-reflow phe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shu-Jian, Luan, Fang-Yun, He, Da-yu, Xu, Feng, Chen, Yu-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408065/ https://www.ncbi.nlm.nih.gov/pubmed/30762768 http://dx.doi.org/10.1097/MD.0000000000014473

Ejemplares similares

Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention
por: Hu, Keqing, et al.
Publicado: (2020)

Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Xu, Xingli, et al.
Publicado: (2020)

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022)

Intracoronary administration of nicorandil during primary percutaneous coronary intervention: Impact on restoration of regional myocardial perfusion in reperfused myocardium during the subacute phase of myocardial infarction
por: Takabatake, Wataru, et al.
Publicado: (2015)

Intracoronary nicorandil induced hyperemia for physiological assessments in the coronary artery lesions
por: Yang, Xia, et al.
Publicado: (2022)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021)

Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction
por: Feng, Chunguang, et al.
Publicado: (2018)

Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
por: Wang, Shanjie, et al.
Publicado: (2019)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
por: Qian, Geng, et al.
Publicado: (2022)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention
por: Sato, Shuji, et al.
Publicado: (2020)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019)

Comparison of myocardial reperfusion between intracoronary versus intravenous cangrelor administration in patients undergoing primary percutaneous coronary intervention
por: Muraca, Iacopo, et al.
Publicado: (2023)

Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
por: Ilyas, Maria, et al.
Publicado: (2023)

Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
por: Scarsini, Roberto, et al.
Publicado: (2023)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Potential Role of Vitamin C Intracoronary Administration in Preventing Cardiac Injury After Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction
por: Shafaei-Bajestani, Negar, et al.
Publicado: (2019)

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
por: Yang, Jing, et al.
Publicado: (2015)

Usefulness of Intracoronary Epinephrine in Severe Hypotension during Percutaneous Coronary Interventions
por: Choi, Jin Hee, et al.
Publicado: (2013)

Intracoronary injection of nitroglycerine can prevent unnecessary percutaneous coronary intervention
por: Nasiri-Partovi, Amirhossein, et al.
Publicado: (2022)

Migration of fully deployed stent after intracoronary glyceryl trinitrate administration: An unusual percutaneous coronary intervention complication
por: Celik, Murat, et al.
Publicado: (2013)

Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Wu, Muli, et al.
Publicado: (2013)

Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention
por: Wang, Weiding, et al.
Publicado: (2019)

Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve
por: Chhabria, Rahul, et al.
Publicado: (2020)

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017)

Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Li, Weijun, et al.
Publicado: (2021)

Oral Presentation Award Winner: Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement
por: Sonoda, Shinjo
Publicado: (2021)

Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease
por: Zong, Yulong, et al.
Publicado: (2021)

Combined thrombectomy and intracoronary administration of glycoprotein IIb/IIIa inhibitors improves myocardial reperfusion in patients undergoing primary percutaneous coronary intervention: a meta-analysis
por: Niu, Xiao-Wei, et al.
Publicado: (2017)

Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study
por: Aksu, Tolga, et al.
Publicado: (2015)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
por: Gao, Ming-Dong, et al.
Publicado: (2020)

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
por: Iversen, Allan, et al.
Publicado: (2008)

Intracoronary Lithoplasty in Percutaneous Treatment of Challenging Calcified Coronary Lesions
por: Marchese, Alfredo, et al.
Publicado: (2020)

Protective effects of nicorandil against cerebral injury in a swine cardiac arrest model
por: Zhu, Fangfang, et al.
Publicado: (2018)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
por: Hahn, JongSung, et al.
Publicado: (2023)

Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials
por: Wang, Xiaobing, et al.
Publicado: (2018)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
por: Ye, Ziliang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a4la5gihb68tm1hjfeo9bhi7sb